These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26439971)

  • 1. Dynamics of immune parameters during the treatment of active tuberculosis showing negative interferon gamma response at the time of diagnosis.
    Matsushita I; Hang NT; Hong le T; Tam do B; Lien LT; Thuong PH; Cuong VC; Hijikata M; Kobayashi N; Sakurada S; Higuchi K; Harada N; Keicho N
    Int J Infect Dis; 2015 Nov; 40():39-44. PubMed ID: 26439971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
    Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
    Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
    Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
    Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.
    Feng JY; Pan SW; Huang SF; Chen YY; Lin YY; Su WJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: A systematic review.
    Clifford V; He Y; Zufferey C; Connell T; Curtis N
    Tuberculosis (Edinb); 2015 Dec; 95(6):639-650. PubMed ID: 26515270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response.
    Sauzullo I; Mengoni F; Ermocida A; Massetti AP; D'Agostino C; Russo G; Salotti A; Falciano M; Vullo V; Mastroianni CM
    New Microbiol; 2014 Apr; 37(2):153-61. PubMed ID: 24858642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a domestic interferon-gamma release assay for detecting Mycobacterium tuberculosis infection in China.
    Liu Y; Ou M; He S; Li X; Lin Y; Xiong J; Zhang J; Ge S
    Tuberculosis (Edinb); 2015 Jul; 95(4):523-6. PubMed ID: 26055815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of interferon-gamma response to mitogen in serial QuantiFERON-TB Gold In-Tube assay of routine laboratory practice.
    Woo KS; Choi JL; Kim BR; Kim JE; Kim BG; Lee H; Kim KH
    Clin Chim Acta; 2014 Mar; 430():79-83. PubMed ID: 24389051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study.
    Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Russomando G; Acosta CCD; Arenas R; Ranaivomanana PP; Razafimahatratra C; Herindrainy P; Rakotonirina J; Raherinandrasana AH; Rakotosamimanana N; Hamze M; Ismail MB; Bayaa R; Berland JL; De Maio F; Delogu G; Endtz H; Ader F; Goletti D; Hoffmann J
    Front Immunol; 2020; 11():616450. PubMed ID: 33603746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between tuberculosis recurrence and interferon-γ response during treatment.
    Hang NT; Matsushita I; Shimbo T; Hong le T; Tam do B; Lien LT; Thuong PH; Cuong VC; Hijikata M; Kobayashi N; Sakurada S; Higuchi K; Harada N; Endo H; Keicho N
    J Infect; 2014 Dec; 69(6):616-26. PubMed ID: 24955986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis.
    Kim CH; Choi KJ; Yoo SS; Lee SY; Won DI; Lim JO; Cha SI; Park JY; Lee J
    Cytometry B Clin Cytom; 2014 Jul; 86(4):236-43. PubMed ID: 23959689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review.
    Chiappini E; Bonsignori F; Accetta G; Boddi V; Galli L; Biggeri A; De Martino M
    Int J Immunopathol Pharmacol; 2012; 25(2):335-43. PubMed ID: 22697065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests.
    Powell RD; Whitworth WC; Bernardo J; Moonan PK; Mazurek GH
    PLoS One; 2011; 6(6):e20061. PubMed ID: 21687702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial interferon-gamma release assays during treatment of active tuberculosis in young adults.
    Lee SW; Lee CT; Yim JJ
    BMC Infect Dis; 2010 Oct; 10():300. PubMed ID: 20950477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.